Drug therapy. Benzodiazepines (second of two parts).
D000342:Affective Symptoms / Q000188:drug therapy; D000437:Alcoholism / Q000188:drug therapy; D000698:Analgesia; D000768:Anesthesia, General; D000773:Anesthesia, Obstetrical; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy; D001552:Benzazepines / Q000009:adverse effects / Q000494:pharmacology / Q000506:poisoning / Q000627:therapeutic use*; D002707:Chlordiazepoxide / Q000627:therapeutic use; D003975:Diazepam / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004554:Electric Countershock; D004724:Endoscopy; D004790:Enzyme Induction / Q000187:drug effects; D005260:Female; D006801:Humans; D007275:Injections, Intravenous / Q000009:adverse effects; D009461:Neurologic Manifestations; D009468:Neuromuscular Diseases / Q000188:drug therapy; D009567:Nitrazepam / Q000627:therapeutic use; D011229:Preanesthetic Medication; D011247:Pregnancy; D011605:Psychoses, Substance-Induced / Q000209:etiology; D012640:Seizures / Q000188:drug therapy; D012893:Sleep Wake Disorders / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D019966:Substance-Related Disorders
D014151:Anti-Anxiety Agents; D001552:Benzazepines; D002707:Chlordiazepoxide; D009567:Nitrazepam; D003975:Diazepam